Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in SEER — Seer, Inc.

CIK 916542 Boston, MA
Back to SEER Full portfolio

Position in SEER

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,243,148
-$242,363 QoQ
Shares Held
1,953,704
-5.8% QoQ
Ownership
3.53%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 59 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SEER Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. SEER ranks #32 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in SEER

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,243,148 1,953,704
2026-03-31 $3,485,511 2,074,709
2025-12-31 $3,735,392 2,041,198
2025-09-30 $4,654,348 2,144,861
2025-06-30 $4,602,495 2,150,699
2025-03-31 $3,634,681 2,150,699
2024-12-31 $4,968,114 2,150,699
2024-09-30 $4,265,861 2,165,412
2024-06-30 $3,027,538 1,802,106
2024-03-31 $2,526,663 1,329,823
2023-12-31 $773,212 398,563
2023-09-30 $539,036 243,908
2023-06-30 $311,867 73,037
2023-03-31 $225,095 58,315